Top Markets
Coin of the day
Agentix Corp. Agentix Corp.

Agentix Corp.

AGTX
Classificação em ações #38792
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Preço da ação
$0.02
Última sincronização: 2026-08-13
Valor de mercado
$801.34K
Variação (1 dia)
0.00%
Variação (1 ano)
-18.70%
País
US
Negociar Agentix Corp. (AGTX)

Categoria

Histórico de preços das ações de Agentix Corp. (AGTX)
Preço de fecho mais alto: $0.02 em 2026-08-01

Preço de fecho mais baixo: $13.07 em 2015-08-01
Histórico de preços das ações da Agentix Corp. de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -6.56%
2025 -78.30%
2024 515.58%
2023 -72.91%
2022 -82.45%
2021 61.22%
2020 -98.30%
2019 128.57%
2018 -65.57%
2017 13.66%
2016 21.09%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$506.92 29.88%
US
$843.33 29.26%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE